Found: 20
Select item for more details and to access through your institution.
Elbasvir/Grazoprevir for HCV Infection in Russia: A Randomized Trial.
- Published in:
- Hepatic Medicine: Evidence & Research, 2020, v. 12, p. 61, doi. 10.2147/HMER.S241418
- By:
- Publication type:
- Article
Effects of multivitamin, multimineral and phytonutrient supplementation on selected nutrient levels in blood and heart health risk factors in Russian population (831.4).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.831.4
- By:
- Publication type:
- Article
Elimination of HCV in Russia: Barriers and Perspective.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 4, p. N.PAG, doi. 10.3390/v14040790
- By:
- Publication type:
- Article
RA06.07: PSYLLIUM SUPPLEMENTATION EFFECT ON ESOPHAGEAL FUNCTION TESTING AND SYMPTOMS IN PATIENTS WITH NON-EROSIVE GERD.
- Published in:
- Diseases of the Esophagus, 2018, v. 31, n. 13, p. 32, doi. 10.1093/dote/doy089.RA06.07
- By:
- Publication type:
- Article
Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 4, p. 335, doi. 10.1111/jvh.13800
- By:
- Publication type:
- Article
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 11, p. 1015, doi. 10.1111/jvh.13741
- By:
- Publication type:
- Article
Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study.
- Published in:
- Nutrients, 2018, v. 10, n. 2, p. 120, doi. 10.3390/nu10020120
- By:
- Publication type:
- Article
Diet and gastroesophageal reflux. correlation analysis.
- Published in:
- Turkish Journal of Gastroenterology, 2019, v. 30, p. S805, doi. 10.5152/tjg.2019.050919
- By:
- Publication type:
- Article
Reduced food diversity in SIBO patients.
- Published in:
- Turkish Journal of Gastroenterology, 2019, v. 30, p. S216, doi. 10.5152/tjg.2019.050919
- By:
- Publication type:
- Article
Randomized trial to assess safety and efficacy of personalized isocalorie and lowcalorie diets in non-alcoholic steatohepatitis.
- Published in:
- Turkish Journal of Gastroenterology, 2019, v. 30, p. S175, doi. 10.5152/tjg.2019.050919
- By:
- Publication type:
- Article
Nutritional patterns in Russian NASH patients.
- Published in:
- Turkish Journal of Gastroenterology, 2019, v. 30, p. S176, doi. 10.5152/tjg.2019.050919
- By:
- Publication type:
- Article
Features of nutrition pattern of patients with resistant to therapy SIBO.
- Published in:
- Turkish Journal of Gastroenterology, 2019, v. 30, p. S170, doi. 10.5152/tjg.2019.050919
- By:
- Publication type:
- Article
Development of Fermented Kombucha Tea Beverage Enriched with Inulin and B Vitamins.
- Published in:
- Fermentation (Basel), 2023, v. 9, n. 6, p. 552, doi. 10.3390/fermentation9060552
- By:
- Publication type:
- Article
Correction to: Ledipasvir–Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Ledipasvir-Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 3, p. 239, doi. 10.1007/s40261-017-0606-0
- By:
- Publication type:
- Article
Helicobacter pylori infection prevalence in ambulatory settings in 2017–2019 in RUSSIA: The data of real‐world national multicenter trial.
- Published in:
- Helicobacter, 2022, v. 27, n. 5, p. 1, doi. 10.1111/hel.12924
- By:
- Publication type:
- Article
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia–Pacific region and Russia: Final results from the randomized C‐CORAL study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 1, p. 12, doi. 10.1111/jgh.14509
- By:
- Publication type:
- Article
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1.
- Published in:
- Journal of Gastroenterology & Hepatology, 2017, v. 32, n. 12, p. 1998, doi. 10.1111/jgh.13796
- By:
- Publication type:
- Article
Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 1, p. 44, doi. 10.1093/cid/ciw676
- By:
- Publication type:
- Article
Is elimination of hepatitis C virus realistic by 2030: Eastern Europe.
- Published in:
- Liver International, 2021, v. 41, p. 50, doi. 10.1111/liv.14836
- By:
- Publication type:
- Article